Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general population
The present results suggest the potential of plasma LECT2 levels as a biomarker for insulin resistance in individuals who are not overweight and the prevalence of MASLD in the general population.
Authors
- Yujiro Nakano (ORCID: https://orcid.org/0000-0003-1620-7164)
- Masao Honda (ORCID: https://orcid.org/0000-0003-3050-5854)
- Atsushi Tajima (ORCID: https://orcid.org/0000-0001-6808-5491)
- Reina Yamamoto
- Hiroyuki Nakamura (ORCID: https://orcid.org/0000-0001-5514-3007)
- Toshinari Takamura (ORCID: https://orcid.org/0000-0002-4393-3244)
- Hiromasa Tsujiguchi (ORCID: https://orcid.org/0000-0001-7511-0165)
- Keita Suzuki (ORCID: https://orcid.org/0000-0003-2833-4080)
- Hisanori Goto (ORCID: https://orcid.org/0009-0008-4723-6156)
- Tatsuya Yamashita (ORCID: https://orcid.org/0000-0002-3602-8086)
- Akinori Hara (ORCID: https://orcid.org/0000-0002-0399-1474)
- Hiroaki Takayama (ORCID: https://orcid.org/0000-0003-4792-3868)
- Yumie Takeshita (ORCID: https://orcid.org/0000-0002-0475-1931)
Institutions
- Kanazawa University (JP)
- Kanazawa Medical University (JP)
Publication Details
- Journal
- Journal of Diabetes Investigation
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1111/jdi.14351
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Japan Agency for Medical Research and Development
- Kanazawa University
- Japan Society for the Promotion of Science